Efficacy and tolerability of bixalomer for treatment of hyperphosphatemia in maintenance hemodialysis patients with poor tolerance to sevelamer: a switching study.
Not Applicable
- Conditions
- Chronic renal failure
- Registration Number
- JPRN-UMIN000010671
- Lead Sponsor
- Keijukai Healthcare Corporation,Saitama Tsukinomori Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with an intestinal blockage 2)Patients suffering from severe astriction or diarrhea continuously 3)Patients who have experienced gastrointestinal tract ulcer or a surgery in the abdomen 4)Patients with liver dysfunction (whose AST or ALT value is more than twice, or T-Bil value is more than 1.5 times higher than the standard level of the hospital they visit), or patients with a severe hepatic disorder such as cirrhosis 5)Patients who are expecting a child, lactating or suspected of pregnancy, or patients who want to be pregnant during their participation in this study 6)Patients considered as ineligible for this study by the investigator for another reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method